Derma Sciences (NASDAQ: DSCI) and Bruker Corporation (NASDAQ:BRKR) are both advanced medical equipment & technology – nec companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Derma Sciences and Bruker Corporation, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Derma Sciences 0 1 0 0 2.00
Bruker Corporation 2 9 3 0 2.07

Bruker Corporation has a consensus target price of $28.90, indicating a potential downside of 14.34%.

Profitability

This table compares Derma Sciences and Bruker Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Derma Sciences -20.97% -17.10% -12.43%
Bruker Corporation 8.85% 25.83% 10.05%

Dividends

Bruker Corporation pays an annual dividend of $0.16 per share and has a dividend yield of 0.5%. Derma Sciences does not pay a dividend. Bruker Corporation pays out 17.0% of its earnings in the form of a dividend.

Earnings & Valuation

This table compares Derma Sciences and Bruker Corporation’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Derma Sciences N/A N/A N/A ($0.31) N/A
Bruker Corporation $1.61 billion 3.26 $153.60 million $0.94 35.89

Bruker Corporation has higher revenue and earnings than Derma Sciences. Derma Sciences is trading at a lower price-to-earnings ratio than Bruker Corporation, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

58.9% of Derma Sciences shares are held by institutional investors. Comparatively, 65.5% of Bruker Corporation shares are held by institutional investors. 9.9% of Derma Sciences shares are held by company insiders. Comparatively, 35.2% of Bruker Corporation shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Bruker Corporation beats Derma Sciences on 10 of the 11 factors compared between the two stocks.

About Derma Sciences

Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company’s advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company’s traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

About Bruker Corporation

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Receive News & Ratings for Derma Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Derma Sciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.